117 related articles for article (PubMed ID: 31757663)
1. The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer.
Wang B; Li H; Wang X; Zhu X
Pathol Res Pract; 2020 Jan; 216(1):152737. PubMed ID: 31757663
[TBL] [Abstract][Full Text] [Related]
2. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
[TBL] [Abstract][Full Text] [Related]
3. Low NLRP3 expression predicts a better prognosis of colorectal cancer.
Shi F; Wei B; Lan T; Xiao Y; Quan X; Chen J; Zhao C; Gao J
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33821998
[TBL] [Abstract][Full Text] [Related]
4. The influence of aberrant expression of GLI1/p-S6K on colorectal cancer.
Wang X; Yao Y; Zhu X
Biochem Biophys Res Commun; 2018 Sep; 503(4):3198-3204. PubMed ID: 30143258
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Promotes Colorectal Cancer Cell Proliferation and Metastasis via Regulating Epithelial Mesenchymal Transformation.
Shao X; Lei Z; Zhou C
Anticancer Agents Med Chem; 2020; 20(7):820-827. PubMed ID: 32077831
[TBL] [Abstract][Full Text] [Related]
6. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer.
Xu Z; Wang H; Gao L; Zhang H; Wang X
Biomed Res Int; 2019; 2019():2170830. PubMed ID: 31886181
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
8. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
[TBL] [Abstract][Full Text] [Related]
10. The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer.
Duan T; Zhou D; Yao Y; Shao X
Front Oncol; 2021; 11():706838. PubMed ID: 34552869
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance and prognostic implication of nuclear factor-κB activation in colorectal cancer.
Pyo JS; Kim EK
Pathol Res Pract; 2019 Aug; 215(8):152469. PubMed ID: 31201065
[TBL] [Abstract][Full Text] [Related]
12. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
13. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.
Deng Q; Geng Y; Zhao L; Li R; Zhang Z; Li K; Liang R; Shao X; Huang M; Zuo D; Wu Y; Ma Q
Cancer Lett; 2019 Feb; 442():21-30. PubMed ID: 30392787
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
Shen X; Bai Y; Luo B; Zhou X
Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
[TBL] [Abstract][Full Text] [Related]
16. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y
J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799
[TBL] [Abstract][Full Text] [Related]
17. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
19. DEPTOR expression negatively correlates with mTORC1 activity and tumor progression in colorectal cancer.
Lai EY; Chen ZG; Zhou X; Fan XR; Wang H; Lai PL; Su YC; Zhang BY; Bai XC; Li YF
Asian Pac J Cancer Prev; 2014; 15(11):4589-94. PubMed ID: 24969890
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer.
Wang ZK; Cheng ZW; Chen SJ; Zhu XG; Gu YP; Yang XD; Sun L; Liu WT; Zhang YJ; Yuan JF; Tian KJ; Yao YZ; He SB
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4509-4517. PubMed ID: 30058685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
